Novel approaches to the development of anti-sepsis drugs.

“Sepsis is the dysregulated systemic immune response to an infection…

The authors discuss specific pharmacological approaches with a focus on immune modulation, for example, Toll-like receptor 4 inhibition and modulation of the endocannabinoid system.”

 http://www.ncbi.nlm.nih.gov/pubmed/24697209

http://www.thctotalhealthcare.com/category/sepsis-2/

Leave a Reply

Your email address will not be published. Required fields are marked *